Human insulin synthesized from A and B chains separately produced in Eschericdia coli from cloned synthetic genes (prepared by the Eli Lilly Research Laboratories, Indianapolis, IN) was characterized by examining its interaction with human cultured lymphocytes, human circulating ervthrocytes in vitro, and isolated rat fat cells. The binding behavior of the biosynthetic insulin with human cells was indistinguishable from that of native human or porcine insulins, with respect to affinity, association and dissociation kinetics, negative cooperativitv, and the down-regulation of lymphocyte receptors. Similarly, the biosynthetic insulin was as potent as the native insulins in stimulating lipogenesis in isolated rat fat cells. We also examined the receptor binding characteristics of '251-labeled human and porcine insulins monoiodinated solelv at Tvr-A14, which were obtained by means of high-performance liquid chromatography of the iodination reaction mixture (this material was prepared by B. Frank, Eli Lillv
. The need to discover alternative sources of insulin production is obvious. Nioreover, l)ecatlse bovine and porcine insulins are immunogenic in a numl)er of diabetic patients (3) , the availability of human insulin might offer considerable advantage.
Recent progress in DNA chemical synthesis and in recombinant DNA technology has allowved the cloning and production of the A and B chains of human insulin in E.scherichia coli from chemically synthesized genes (4, 5) . After purification of the A and B chains bw high-performance liquid chromatography (HPLC), human insulin has been sylnthesized 1w the formation of the correct disulfide bonds (6-8, *) and shown to be radioimmunologicallv reactive (5) .
In the present work, we have studied the binding of this "biosvnthetic" human (HBHN) insulin to human insulin receptors and compared its properties to those of native human (HNA-T) and porcine (P) instulins. The characteristics of all three insulins were the same with respect to all binding properties studied, as well as to the ability to induce down-regulation of receptors in lymphocytes and to elicit a biological response in vitro in isolated rat fat cells. The iodination of insulin can result in the labeling of Tvr-A14, Tyr-A19, or various B-chain residues (9) . Iodination 1w the stoichiometric chloramine-T (10, 11) or lactoperoxidase (12) methods results in iodination primarily but not exclusively at Tvr-A14 (9) . Studies of homogeneous insulins labeled wvith 125i at Tvr-A14 or Tyr-A19 (A14-'1 -insulin and A19-'2'I-insulin, resp)ectively) have shown the A19 derivative to be only half as active as the A14 derivative (9) . W\e used this study as an opportuinity to compare the binding properties of insulin monoiodinated 1b the stoichiometric method and purified 1b gel filtration, as dolne in most laboratories (including ours), with those of a carrier-free A14-1-21-inisutlin1 obtained 1y one-step purification with HPLC (13) . It is clear that the HPLC method of purification, like the polvacrylamide gel electrophoresis method (9) , yields a tracer of much higher quality for receptor studies.
MATERIALS AND METHODS Insulins. P insulin (lot 121042) was a gift from Novo (Copenhagen, l)enmark). H't"" insulin (4, 5 (14) . The His"' and HoNA insulins were gifts firom Ronald Chance through the courtesy of Herman Debruvne (Eli Lilly, Benelux). Homogeneous P and H IoA14-l25I-insulins were prepared by lactoperoxidase iodination, purified by means of HPLC using a RP-1/C18 reverse-phase system (13) , and kindly provided by Bruce Frank (Eli Lilly Research Laboratories) (exact methods to be pul)lished elsewhere). We iodinated P insulin with 125i (Na'251, IMlS-300, Amersham) as described (11) to a specific activity of 180.9 /.Ci (1 Ci = 3. 7 x 10'( l)ec(querels) per tig (average 0.5 mol of 1251 per mol of insulin) and purified it by elution on a superfine Sephadex G-75 column (1.6 x 28 cm). Samples of the two HPLC-purified insulins were run on the samne column. All three tracers satisfied the chromatographic criteria of a "good tracer." Aggregated insulin and degraded fragments were undetectable. The .5% trichloroacetic acid precipitabilitv was 97.4%, 98.6%, and 98.4%, respectively, for our labeled P insulin and the Lilly HB"o and P A14-'2'I-insulin tracers.
Growth of Cultured Lymphocytes. Human lymphocytes (line I-M-9) were maintained at 370C in RPMI 1640 medium supplemented with 10% fetal calf serum, penicillin at 100 units/ ml, and streptomvcin at 100 ,tg/ml, 1w feeding three times a week (11, 15) .
Lymphocyte Binding Assay. The conditions for the lymphocvte binding assay and measurement of association kinetics and dissociation kinetics have been extensively described elsewhere (11, (15) (16) (17) insulins in the presence of unlabeled insulin at 10 ,pg/ml was measured and subtracted as "nonspecific binding" (11) to yield specific binding data. These data were then analyzed according to Scatchard (11, 18) or as average affinity profiles (19) .
Erythrocyte Binding Assay. Binding of the 125I-insulins to circulating human erythrocytes from a normal donor was determined according to Gambhir et al. (20) . The specific binding data were calculated and analyzed as described above (11, 18, 19) . Down-Regulation. Cultured human lymphocytes were preincubated for 16 hr at 370C with concentrations of insulin ranging from 1 to 100 nM, collected by centrifugation, and washed three times in assay buffer. We determined the residual binding capacity as described (15) .
Lipogenesis in Rat Adipocytes. The ability of each of the three insulins to stimulate lipogenesis in isolated rat fat cells was determined according to Gliemann and coworkers (21, 22) . In contrast, the binding of the porcine tracer purified by conventional methods was lower at all time points. It reached equilibrium at the same time as the other iodinated insulins, and the half-time was similar (44 min). The initial rate (Fig. 1 Inset) of association of the conventional porcine tracer was approximately 69% of that of the HPLC-purified tracers. Dissociation Kinetics. The dissociations of all three tracers from IM-9 lymphocytes at 150C, in 1:40 dilutions, were nearlv identical ( Fig. 2A) . Each dissociation showed non-first-order kinetics and was accelerated to the same extent by the presence in the dilution medium of the respective unlabeled tracer at 0.17 AM (Fig. 2A) . Moreover, the dose-response curves for the accelerating effect of the three unlabeled insulins tested were superimposable (Fig. 2B) . Unlabeled P insulin was equally effective in enhancing the dissociation of either HBI" A14-125I-insulin or our P 1251-insulin.
Competition Curves. Each of the three labeled insulins was incubated to equilibrium at 15'C (with lymphocytes or erythrocytes) in the absence or presence of increasing concentrations of each of the three unlabeled species. The competition curves (Fig. 3) determined for the three unlabeled insulins were superimposable with all three tracers and with both types of human cells, despite the lower initial binding of the conventional porcine tracer.
Scatchard Plots. The experiment described in Fig. 3 was conducted for each of the three tracers with its homologous insulin, using identical concentrations of lymphocytes from the same pool of cells. When these binding data or the erythrocyte binding data of Fig. 3 were analyzed according to Scatchard (18) , curvilinear plots were obtained (Fig. 4) . The horizontal intercept indicates the maximal binding capacity or receptor concentration (R.) and was the same for the three labeled and three unlabeled insulins. However, the bound/free ratio was lower at every point when the conventional porcine tracer was used, corresponding to a lower apparent affinity measured with this tracer. This was true with both types of human cells. The average affinity profiles of these data (not shown), when normalized to the initial binding, were superimposable, indicating that the relative falls in apparent affinity occurring with progressive saturation are comparable and independent of the tracer used.
Down-Regulation. The abilities of three different concentrations of the three unlabeled insulins to down-regulate the receptors in IM-9 lymphocytes during a 16-hr preincubation at 370C were compared. All three insulins decreased the binding to comparable extents (Fig. 5) at equivalent doses.
Stimulation of Lipogenesis in Rat Fat Cells. Because no such biological effect of insulin has been described in the human cells used in this study, we tested the abilitv of the three unlabeled insulins to stimulate the incorporation of [3-3H] glucose into the lipids of isolated rat fat cells (21, 22) . The dose-response curves of the three insulins were superimposable (Fig. 6 ).
DISCUSSION
The HBIO insulin recombined from isolated A and B chains produced bv E. coli after cloning of synthetic genes (4, 5) was identical to native pancreatic human (HNAT) and porcine (P) insulins ed with increasing concentrations (as in Fig. 3 ) of the homologous unlabeled insulin. The bound/free radioactivity at equilibrium is plotted as a function of bound hormone. (B) Binding data of Fig. 3D were replotted as the bound/free radioactivity as a function of bound insulin. Symbols are the same as in Fig. 3D .
with respect to all properties examined: binding affinity, kinetics of association and dissociation, down-regulation of receptors, and stimulation of lipogenesis. The binding of insulin to its receptors is crucially dependent on the integrity of the tertiary structure of the insulin molecule (23) as well as on the conservation of a number of invariant surface residues involved in the receptor-binding region (24, 25) . A single amino-acid substitution in this region, as recently found in a rare case of human diabetes caused by the secretion of an abnormal insulin, can cause marked impairment in the receptor binding and biological effect of insulin (26) .
Therefore, the superimposable receptor-binding competition curves of the unlabeled HNAT and HBIo insulins, as well as the superimposable kinetics of the HBIo and P A14-'25I-insulins, suggest that the tertiary as well as the primary structures of the biosynthetic molecule have been integrally reconstituted. This agrees well with its intact biological potency in vitro. Thus, the integrity of a human hormone prepared by genetic x 10W per ml), and incubated with HB10 A14-1251-insulin (13 We have also examined the ability of the unlabeled HBIO insulin to accelerate the dissociation rate of labeled insulins from the receptor, as well as the ability of H MO A14-'251-insulin to have its dissociation rate accelerated by an unlabeled species. We have previously interpreted this property as the ability of the hormone to induce receptor-mediated affinity changes (negative cooperativity) (11, 16, 17, 19, 25) . Although it has been challenged (27-29), we still believe that our original interpretation is the most plausible, both on theoretical grounds (30) and on the basis of recent experimental data (31, t, :), as discussed elsewhere (32, 33) . In this study, we have simply used the ob- hvpoglvcemic potency of the HBI() insulin in healthy men stressed minor differences from P insulin (36) . There is clearly no indication of such differences in our results.
In this same study, we have confirmed and extended the observations of Gliemann and his coworkers (9) that an insulin tracer iodinated exclusively on Tvr-A14 binds much better to the insulin receptor than does the A19-125I isomer or the mixture of isomers obtained with conventional purification. Both A14-labeled tracers appear to have a remarkably longer lifetime and have been used for more than 2 months without a loss of integrity as determined by binding studies, trichloroacetic acid precipitabilitv, and gel filtration. Because purification by HPLC yields the desired product in a single step, this technique (13, 37) appears to be the method of choice for those with access to such equipment. The use of A14-125I-insulin should be of major advantage in clinical studies using circulating human cells, to which the binding is normally low, as is evident in Fig.   3D .
The higher affinity of the A14 isomer was shown here to be primarily due to a faster initial rate of association and not to a difference in dissociation kinetics, which remained multiexponential. The use of the conventional tracer thus results only in an underestimation of the affinity of the receptor, affecting neither the curvilinearitv of the Scatchard plot nor the measurement of receptor concentration or down-regulation. The conclusions of our previous studies of the dissociation kinetics are similarly not affected.
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